Skip to contentO
Oragenics Inc
O
OGENOragenics Inc Q2 2013 · 10-Q
Revenue$167.67K$167.67K−34.6% vs Q2 2012 Net Income-$2.07M-$2.07MN/M vs Q2 2012 EPS Diluted-$0.08-$0.08N/M vs Q2 2012 Gross Profit$81,011−43.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,000,238N/M Margins · derivedGross margin48.3%−7.9 pt vs Q2 2012
Operating margin-1237.7%+1441.1 pt vs Q2 2012
Net margin-1237.0%+1465.3 pt vs Q2 2012
ended Jun 30, 2013 · filed Aug 12, 2013 · 43 d after period end